Off-label use in child and adolescent psychiatry : AAn ongoing ethical, medical and legal problem;Off-label-use von psychopharmaka in der kinder- und jugendpsychiatrie : Ein andauerndes ethisches, medizinisches und rechtliches problem

Nervenarzt

Volumn 80, Issue 7, 2009, Pages 789-796

  Kolch M ^a   Allroggen, M ^a   Fegert, J M ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Antipsychotics; Child and adolescent psychiatry; Off label use; SSRI Literatur:

Indexed keywords

ATOMOXETINE; CLOZAPINE; FLUOXETINE; FLUPHENAZINE; FLUVOXAMINE MALEATE; HALOPERIDOL; LOXAPINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TIOTIXENE;

AGGRESSION; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD BEHAVIOR; CHILD PSYCHIATRY; DRUG EFFICACY; DRUG LABELING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EUROPE; GERMANY; HEALTH INSURANCE; HUMAN; IMPULSIVENESS; LEGAL ASPECT; MAJOR DEPRESSION; MEDICAL LIABILITY; OFF LABEL DRUG USE; PSYCHOSIS; REIMBURSEMENT; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; UNITED STATES;

ADOLESCENT; ADOLESCENT PSYCHIATRY; CHILD; CHILD PSYCHIATRY; DRUG LABELING; GERMANY; HUMANS; MENTAL DISORDERS; UNITED STATES;

EID: 67651146351     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2727-z     Document Type: Review

References (53)

1. Alacqua 2008 Pharm World Sci 30 44
2. Aras 2007 Child Care Health Dev 33 482
3. Armenteros 2006 Eur Child Adolesc Psychiatry 15 141
4. Bua 2008 Arch Dis Child 93 546
5. Bucheler 2002 BMJ 324 1311
6. Caldwell 2004 Lancet 364 803
7. Clark 2004 J Psychopharmacol 18 115
8. Clavenna 2007 Eur J Pediatr 166 339
9. Conroy 2000 BMJ 320 79
10. Dell 2008 Child Adolesc Psychiatr Clin N Am 17 93
11. Doey 2007 Can J Psychiatry 52 363
12. Efron 2003 Pediatrics 111 372
13. Fegert 2003 Child Adoles Psychopharmacology News 8 5
14. Fegert 2000 Deutsches Ärzteblatt 97 A29
15. Fegert 2003 Zeitschrift für Rechtspolitik 36 446
16. Fegert 2006 J Child Adolesc Psychopharmacol 16 197
17. Frazier 2007 J Am Acad Child Adolesc Psychiatry 46 979
18. Gerlach 2007 Pharmacopsychiatry 40 72
19. Gerlach 2006 Z Kinder Jugendpsychiatr Psychother 34 5
20. Gerlach 2005 Z Kinder Jugendpsychiatr Psychother 33 157
21. Gibbons 2007 Am J Psychiatry 164 1356
22. Groleger 2007 Psychiatr Danub 19 350
23. Hammad 2006 Arch Gen Psychiatry 63 332
24. Hazell 1995 BMJ 310 897
25. Holtmann 2007 Bipolar Disord 9 895
26. Holtmann 2008 Arch Gen Psychiatry 65 477
27. Holtmann 2008 J Neural Transm 115 155
28. Hopf 2002 Dtsch Arztebl 99 1069
29. Horen 2002 Br J Clin Pharmacol 54 665
30. Kimland 2007 Eur J Pediatr 166 527
31. Kölch M, Berg Lvd, Janhsen K (2009) Prevalence and incidence of antidepressants in children and adolescents in Germany and the Netherlands - changes in prescribing patterns after (in preparation)
32. Kölch 2007 Prax Kinderpsychol Kinderpsychiatr 56 224
33. Kölch 2006 Z Kinder Jugendpsychiatr Psychother 34 117
34. Kölch 2007 Eur Child Adolesc Psychiatry 16 229
35. Kölch 2008 Curr Opin Psychiatry 21 598
36. Kumra 2008 Schizophr Bull 34 60
37. Madaan 2008 Expert Opin Pharmacother 9 2053
38. McClellan 2007 J Am Acad Child Adolesc Psychiatry 46 969
39. McClellan 2007 Am J Psychiatry 164 1462
40. Mehler-Wex 2008 Dtsch Arztebl 105 149
41. Pool 1976 Curr Ther Res Clin Exp 19 99
42. Rivkees 2007 J Pediatr Endocrinol Metab 20 171
43. Rothärmel S, Dippold I, Wiethoff K, Wolfslast G (2006) Patientenaufklärung, Informationsbedürfnis und Informationspraxis in der Kinder- und Jugendpsychiatrie. Göttingen
44. Schepker 2007 Z Kinder Jugendpsychiatr Psychother 35 207
45. Sikich 2008 Am J Psychiatry 165 1420
46. Spencer 1992 Psychopharmacol Bull 28 183
47. Turner 1998 BMJ 316 343
48. Turner 1999 Acta Paediatr 88 965
49. Vitiello 2007 Psychopharmacology 191 5
50. Waller 2007 Br J Clin Pharmacol 64 1
51. Zito 2008 Child Adolesc Psychiatry Ment Health 2 26
52. Zito 2007 J Child Adolesc Psychopharmacol 17 195
53. Zito 2006 Pharmacoepidemiol Drug Saf 15 793